Xspray Pharma approved for listing on Nasdaq Stockholm
STOCKHOLM – March 18, 2020. Xspray Pharma (Nasdaq First North Growth Market: XSPRAY) announces that Nasdaq Stockholm’s listing committee has approved the company’s application to be listed on Nasdaq Stockholm’s main market. The approval is conditional upon the fulfilment of customary conditions, among others that a prospectus is approved and registered by the Swedish Financial Supervisory Authority (“SFSA”). The trading of the company’s shares on Nasdaq Stockholm’s main market is expected to commence on Friday 27 March 2020, and the last day of trading on Nasdaq First North Growth Market is